2024

1. Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C

   Journal for ImmunoTherapy of Cancer, Vol. 12, Núm. 4

2. Low-Dose Ionizing γ-Radiation Elicits the Extrusion of Neutrophil Extracellular Traps

   Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 30, Núm. 18, pp. 4131-4142

3. MHC class I and II-deficient humanized mice are suitable tools to test the long-term antitumor efficacy of immune checkpoint inhibitors and T-cell engagers

   Journal for immunotherapy of cancer, Vol. 12, Núm. 9

4. Non-mitogenic FGF19 mRNA-based therapy for the treatment of experimental metabolic dysfunction-associated steatotic liver disease (MASLD)

   Clinical science (London, England : 1979), Vol. 138, Núm. 20, pp. 1265-1284

5. Preclinical evaluation of two phylogenetically distant arenavirus vectors for the development of novel immunotherapeutic combination strategies for cancer treatment

   Journal for ImmunoTherapy of Cancer, Vol. 12, Núm. 4

6. Systemic messenger RNA replacement therapy is effective in a novel clinically relevant model of acute intermittent porphyria developed in non-human primates

   Gut

7. Targeting metalloproteases is a promising strategy to enhance immunotherapy responses by overcoming immune exclusion in hepatocellular carcinoma

   Gut

8. The liver as a cytokine factory working on mRNA blueprints for cancer immunotherapy

   Cancer Cell

9. Tumor slice culture system for ex vivo immunotherapy studies

   Methods in Cell Biology, Vol. 189, pp. 55-69

10. Unveiling the multifaceted antitumor effects of interleukin 33

    Frontiers in Immunology